| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |